查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
亞太地區數位 PCR 市場按應用、最終用戶和國家分類 - 分析和預測（2024-2034 年）
市場調查報告書
商品編碼
1676618

亞太地區數位 PCR 市場按應用、最終用戶和國家分類 - 分析和預測（2024-2034 年）

Asia-Pacific Digital PCR Market: Focus on Application, End User, and Country Analysis - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 62 Pages | 商品交期: 1-5個工作天內

價格

亞太地區數位 PCR (d-PCR) 市場規模預計將從 2024 年的 1.444 億美元成長到 2034 年的 6.955 億美元，2024-2034 年預測期間的複合年成長率為 17.02%。

個人化醫療在遺傳疾病篩檢和診斷的應用日益廣泛，推動了亞太地區數位 PCR 市場實現兩位數成長。這種針對患者的方法採用數位 PCR (dPCR) 來準確識別和測量與各種癌症相關的罕見基因突變。該地區感染疾病疫情的不斷增加也加劇了對快速、準確診斷解決方案的需求。液滴數位 PCR、奈米板技術和微流體平台是一些技術進步，它們正在提高 dPCR 的功能並顯著推動亞太地區市場的成長。

主要市場統計數據
預測期 2024-2034
2024 年評估 1.444億美元
2034 年預測 6.955億美元
複合年成長率 17.02％

在亞太地區，數位聚合酵素鏈鎖反應（dPCR）市場正在經歷強勁的兩位數成長，並迅速成為一種尖端的診斷技術。隨著政府計畫數量的增加、醫療保健基礎設施投資的增加以及研究資金的增加，dPCR 在臨床和研究中的廣泛應用正在推動。感染疾病、遺傳性疾病和癌症發病率的上升推動了亞太地區對精準診斷的需求，以便早期發現疾病並有效監測治療。

先進的dPCR技術顯著提高了靈敏度、特異性和通量。這些技術的例子包括液滴數位 PCR、奈米板系統和微流體平台。這些發展將能夠準確量化低豐度生物標記（例如罕見基因突變），從而支持標靶治療和個人化醫療。此外，透過順利融入標準臨床工作流程，實現了快速的周轉時間和較低的營運成本，這得益於自動化和直覺軟體介面的進步。

亞太地區數位 PCR 市場具有進一步成長和技術進步的良好條件，這將最終改變全部區域的分子診斷模式。這是因為領先的現有企業和新興的新興企業都在投資研發，以解決該地區獨特的臨床挑戰。

本報告研究了亞太地區數位 PCR 市場，並提供了市場概述、按應用、最終用戶和國家分類的趨勢，以及參與市場的公司概況。

目錄

執行摘要

第1章 市場

  • 市場概況
  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研發回顧
  • 正在進行的數位 PCR 臨床試驗
  • 市場動態概覽

第2章 區域

  • 區域概況
  • 促進因素與限制因素
  • 亞太地區

第3章 市場競爭基準化分析與公司概況

  • 競爭格局
  • 市場佔有率分析
  • 公司簡介
    • Genetron Holdings Limited
    • RevoSketch Inc.
    • JN Medsys
    • Sysmex Corporation

第4章調查方法

Product Code: BHP2685SS

Introduction to Asia-Pacific Digital PCR Market

The Asia-Pacific digital PCR (d-PCR) market is projected to reach $695.5 million by 2034 from $144.4 million in 2024, growing at a CAGR of 17.02% during the forecast period 2024-2034. The growing use of personalised medicine for genetic disorder screening and diagnosis has propelled the APAC digital PCR market's double-digit growth. Digital PCR (dPCR) is used in this patient-specific method to precisely identify and measure uncommon genetic mutations connected to a range of cancers. The need for quick and accurate diagnostic solutions is also being fuelled by the region's rising infectious disease prevalence. Droplet digital PCR, nanoplate technology, and microfluidic platforms are examples of technological advancements that are improving dPCR capabilities and greatly bolstering the market's growth in the Asia-Pacific area.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$144.4 Million
2034 Forecast$695.5 Million
CAGR17.02%

The Asia-Pacific (APAC) region is seeing strong, double-digit growth in the digital polymerase chain reaction (dPCR) market, which is quickly becoming popular as a state-of-the-art diagnostic technique. The broad use of dPCR in clinical and research applications is being fuelled by increased government programs, increased investments in healthcare infrastructure, and improved research funding. The need for high-precision diagnostics that facilitate early disease detection and efficient treatment monitoring is increasing in APAC due to the rising incidence of infectious diseases, genetic disorders, and cancers.

Advanced dPCR technologies have greatly increased sensitivity, specificity, and throughput. Examples of these technologies include droplet digital PCR, nanoplate systems, and microfluidic platforms. These developments support targeted therapies and personalised medicine by enabling the accurate quantification of low-abundance biomarkers, such as uncommon genetic mutations. Additionally, quicker turnaround times and lower operating costs are being achieved through smooth integration into standard clinical workflows made possible by advancements in automation and intuitive software interfaces.

The APAC digital PCR market is well-positioned for further growth and technological advancement, which will ultimately change the molecular diagnostics landscape throughout the region. This is due to the fact that both established industry leaders and up-and-coming startups are investing in research and development to create solutions for the region's particular clinical challenges.

Market Segmentation:

Segmentation 1: by Application

  • Clinical and Research Application
  • Environmental Application
  • Other Application

Segmentation 2: by End User

  • Academic and Research Institutes
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Other End User

Segmentation 3: by Country

  • China
  • Japan
  • South Korea
  • Australia
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific digital PCR market has numerous established players with product portfolios. Key players in the APAC digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • RevoSketch Inc.
  • JN Medsys
  • Sysmex Corporation

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Market Overview
    • 1.1.1 Workflow of Digital PCR
    • 1.1.2 Comparison of qPCR and dPCR
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Integration with Next-Generation Sequencing (NGS)
    • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
    • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
  • 1.3 Supply Chain Overview
  • 1.4 Research and Development Review
    • 1.4.1 Patent Filing Trend (by Region)
    • 1.4.2 Patent Filing Trend (by Country)
    • 1.4.3 Patent Filing Trend (by Year)
  • 1.5 Ongoing Digital PCR Clinical Trials
  • 1.6 Regulatory Landscape
    • 1.6.1 Asia Pacific
      • 1.6.1.1 Japan
      • 1.6.1.2 China
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
      • 1.7.1.2 Increasing Incidence of Infectious Diseases
      • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
    • 1.7.2 Market Restraints
      • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
      • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
      • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Asia-Pacific
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 Application
    • 2.3.5 By End User
    • 2.3.6 China
    • 2.3.7 Australia
    • 2.3.8 South Korea
    • 2.3.9 Japan
    • 2.3.10 Rest-of-Asia-Pacific

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
  • 3.2 Market Share Analysis
  • 3.3 Company Profile
    • 3.3.1 Genetron Holdings Limited
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personnel
      • 3.3.1.6 Analyst View
    • 3.3.2 RevoSketch Inc.
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personnel
      • 3.3.2.6 Analyst View
    • 3.3.3 JN Medsys
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personnel
      • 3.3.3.6 Analyst View
    • 3.3.4 Sysmex Corporation.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personnel
      • 3.3.4.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Digital PCR Market (by Application), $Million 202, 2029 and 2034
  • Figure 2: Asia-Pacific Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
  • Figure 3: Key Events to Keep Track of in the Digital PCR Market
  • Figure 4: Supply Chain and Risks within the Supply Chain
  • Figure 5: Digital PCR Market (by Region), January 2020-September 2024
  • Figure 6: Digital PCR Market (by Country), January 2020-September 2024
  • Figure 7: Digital PCR Market (by Year), January 2020-September 2024
  • Figure 8: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 9: China Digital PCR Market, $Million, 2023-2034
  • Figure 10: Australia Digital PCR Market, $Million, 2023-2034
  • Figure 11: South Korea Digital PCR Market, $Million, 2023-2034
  • Figure 12: Japan Digital PCR Market, $Million, 2023-2034
  • Figure 13: Rest-of-Asia-Pacific Digital PCR Market, $Million, 2023-2034
  • Figure 14: Strategic Initiatives, January 2019-September 2024
  • Figure 15: Share of Strategic Initiatives, January 2019-September 2024
  • Figure 16: Data Triangulation
  • Figure 17: Top-Down and Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 18: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Comparison of qPCR and dPCR
  • Table 4: Digital PCR Market, Trend Analysis
  • Table 5: Digital PCR Market, Recent Product Launches
  • Table 6: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
  • Table 7: Regulatory Framework
  • Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
  • Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
  • Table 10: Digital PCR Market (by Region), $Million, 2023-2034
  • Table 11: Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
  • Table 12: Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034
  • Table 13: China Digital PCR Market (by Application), $Million, 2023-2034
  • Table 14: China Digital PCR Market (by End User), $Million, 2023-2034
  • Table 15: Australia Digital PCR Market (by Application), $Million, 2023-2034
  • Table 16: Australia Digital PCR Market (by End User), $Million, 2023-2034
  • Table 17: South Korea Digital PCR Market (by Application), $Million, 2023-2034
  • Table 18: South Korea Digital PCR Market (by End User), $Million, 2023-2034
  • Table 19: Japan Digital PCR Market (by Application), $Million, 2023-2034
  • Table 20: Japan Digital PCR Market (by End User), $Million, 2023-2034
  • Table 21: Rest-of-Asia-Pacific Digital PCR Market (by Application), $Million, 2023-2034
  • Table 22: Rest-of-Asia-Pacific Digital PCR Market (by End User), $Million, 2023-2034